Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,137.90
(
1.05%
)
US TECH 100
26,230.40
(
1.77%
)
Dow Jones
49,490.03
(
0.09%
)
Brent Oil
96.77
(
1.85%
)
Bitcoin
78,809.05
(
3.25%
)
News Focus
News Focus
Post# of 347009
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

revenue_monster

Send PM Follow Ignore
Followers 27
Posts 6609
Boards Moderated 0
Alias Born 09/30/2012

revenue_monster

Re: Protector post# 260888

Tuesday, 04/05/2016 6:19:43 PM

Tuesday, April 05, 2016 6:19:43 PM

Post# of 347009
The did tell us they stopped the trial. What are you waiting for? I would say stopped and discontinued are one in the same.
TUSTIN, Calif., Feb. 25, 2016 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the body's immune system to fight cancer, today announced that it is discontinuing the company's Phase III SUNRISE trial of bavituximab in patients with previously treated locally advanced or metastatic n
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote